DEFERASIROX Spirig HC cpr pellic 900 mg 30 pce

7680688710076 Pharmacode 1134894 CH-68871 V03AC03 06.99.0.

Active substances:

DEFERASIROX Spirig HC cpr pellic 900 mg 30 pce
DEFERASIROX Spirig HC cpr pellic 900 mg 30 pce
DEFERASIROX Spirig HC cpr pellic 900 mg 30 pce
1 / 3
google

Details

GTIN
7680688710076
Pharmacode
1134894
Product number
6887104
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
deferasiroxum 900 mg, cellulosum microcristallinum, crospovidonum, povidonum K 30, poloxamerum 188, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, macrogolum 4000, talcum, E 171 pro compresso obducto.

Articles (1)

Deferasirox Spirig HC 900 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/12/2024
Patient information leaflet
Français
04/12/2024
Patient information leaflet
Italien
04/12/2024
Professional SmPC
Allemand
04/12/2024
Professional SmPC
Français
04/12/2024
Professional SmPC
Italien
04/12/2024

Detailed composition

Substance Quantity Type Category
deferasiroxum
900.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
crospovidonum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
magnesii stearas
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK

Reimbursement information

Public price
CHF 876.35
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2025

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68871
Drug name
Deferasirox Spirig HC, Filmtabletten
Galenic form
FILM
ATC Code
V03AC03
Authorization status
Z
Dispensation category
B
First authorization
17/02/2023
Authorization expiration date
16/02/2028
IT number
06.99.0.
Domain
Human medicine
Field of application
Behandlung der transfusionsbedingten Hämosiderose. Behandlung von chronischer Eisenüberladung, die eine Chelattherapie erfordert, bei Patienten mit nicht-transfusionsabhängiger Thalassämie ab 10 Jahren.

Packaging details

Description (FR)
DEFERASIROX Spirig HC cpr pellic 900 mg 30 pce
Description (DE)
DEFERASIROX Spirig HC Filmtabl 900 mg 30 Stk
Market launch
16/08/2024
Narcotic (BTM)
No

Original drug

Jadenu, Filmtabletten
CHF 221.40
View original

Other packaging sizes

DEFERASIROX Spirig HC cpr pellic 90 mg 30 pce
30 TABL
View
DEFERASIROX Spirig HC cpr pellic 90 mg 90 pce
90 TABL
View
DEFERASIROX Spirig HC cpr pellic 180 mg 30 pce
30 TABL
View
DEFERASIROX Spirig HC cpr pellic 180 mg 90 pce
90 TABL
View
DEFERASIROX Spirig HC cpr pellic 360 mg 30 pce
30 TABL
View
DEFERASIROX Spirig HC cpr pellic 360 mg 90 pce
90 TABL
View
DEFERASIROX Spirig HC cpr pellic 900 mg 90 pce
90 TABL
View
Buy us a coffee Explore the data